Island Psychiatry P.C. TMS at all 3 of our locations:

**55 Nesconset Highway, Suite 1

Port Jefferson Station, NY 11776

**33 Walt Whitman Rd Suite 217W

Huntington Station, NY 11746

**646 Main St Suite 201

Port Jefferson, NY 11777

Island TMS

Open Monday - Friday 

Evening Hours on Monday and Thursdays

DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE

The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. The purpose of this website is to promote broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Transcranial magnetic stimulation is gaining ground as a therapy for treatment-resistant depression.

By Kirsten Weir

February 2015, Vol 46, No. 2

Results Observed With the First 100 Consecutive Cases of Depression at an Academic Medical Center

K. Ryan Connolly, MD; Amanda Helmer, RN; Mario A. Cristancho, MD; Pilar Cristancho, MD; and John P. O’Reardon, MD

J Clin Psychiatry 2012;73(4):e567-e573

10.4088/JCP.11m07413

© Copyright 2012 Physicians Postgraduate Press, Inc.

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States:

O’Reardon JP, Solvason HB, Janicak PG, et al.

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multi-site randomized controlled trial. Biological Psychiatry 2007; 62, 1208-16. Demitrack, MA, Thase, ME.

 

Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmaco-resistant depression: synthesis of recent data. Psychopharm Bull. 2009, 42(2): 5-38.

Transcranial Magnetic Stimulation or Neuromodulation for Depression

The system is currently being assessed for its use in stroke rehabilitation in the Phase 3 supplemental study 'E-FIT', involving 60 patients. The trial is expected to be complete in Q2 2018, allowing the Company to file for clearance of this indication.

In the past, the most common treatments for depression have been medication and/or psychotherapy. With TMS, psychotherapy is still encouraged because it can help people maintain mental health. However, unlike antidepressants, TMS has few if any side effects. 

Major depression is one of the most common mental health disorders in the U.S., affecting more than 16 million adults, 2015 figures show. Repetitive treatments using TMS have been shown to effectively treat patients with major depression for whom drugs have not worked.